CERo Therapeutics Holdings, Inc.
CERO
$0.01
$0.00-9.91%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.70M | -19.92M | -14.71M | -14.08M | -11.11M |
| Total Depreciation and Amortization | 1.09M | 1.09M | 1.09M | 1.12M | 1.14M |
| Total Amortization of Deferred Charges | 742.20K | 605.40K | 500.00K | -- | -- |
| Total Other Non-Cash Items | 3.99M | 1.96M | -2.04M | -2.14M | -4.99M |
| Change in Net Operating Assets | 477.00K | 189.20K | 1.33M | 1.73M | 2.67M |
| Cash from Operations | -14.40M | -16.08M | -13.81M | -13.37M | -12.28M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 500.00K | 500.00K | 500.00K | -- | -- |
| Cash from Investing | 500.00K | 500.00K | 500.00K | -- | -- |
| Total Debt Issued | 1.50M | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -102.30K | -253.20K | -402.50K |
| Issuance of Common Stock | 4.63M | 6.71M | 5.92M | 7.83M | 5.10M |
| Repurchase of Common Stock | -962.00K | -962.00K | -962.00K | -- | -4.53M |
| Issuance of Preferred Stock | 5.26M | 5.76M | 4.07M | 2.69M | 9.95M |
| Repurchase of Preferred Stock | 0.00 | -395.00K | -395.00K | -395.00K | -395.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -874.70K | 2.81M | 3.42M | 3.16M | 3.17M |
| Cash from Financing | 9.55M | 13.92M | 11.96M | 13.02M | 12.89M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.35M | -1.66M | -1.36M | -344.30K | 610.50K |